# Cortical Metrics Assessment Outcome Measure Development in Autism With Memantine Treatment

> **NCT02353130** · — · WITHDRAWN · sponsor: **University of North Carolina, Chapel Hill**

## Conditions studied

- Autism Spectrum Disorders

## Interventions

- **DRUG:** Memantine-XR

## Key facts

- **NCT ID:** NCT02353130
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-07
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Protocol did not continue once Investigator relocated to another institution
- **Last updated:** 2017-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02353130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02353130, "Cortical Metrics Assessment Outcome Measure Development in Autism With Memantine Treatment". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02353130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*